VYNE CFO has shares withheld for RSU taxes
VYNE Therapeutics Inc. chief financial officer Tyler Zeronda reported a routine tax-related share disposition.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
VYNE Therapeutics Inc. chief financial officer Tyler Zeronda reported a routine tax-related share disposition. On June 30, 2026, 3,464 shares of common stock were withheld at $0.6507 per share to cover tax obligations arising from the vesting of restricted stock units. After this withholding, Zeronda directly held 97,434 shares of VYNE common stock, indicating the event was compensation- and tax-driven rather than an open-market sale.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Common Stock | 3,464 | $0.6507 | $2K |
Footnotes (1)
- F1. Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.
Key Figures
Key Terms
restricted stock units financial
tax withholding requirements financial
tax-withholding disposition financial
Common Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did VYNE (VYNE) report for its CFO?
What does transaction code F mean in the VYNE Form 4 filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.